Imunisasi Word Print

8/17/2019 Imunisasi Word Print

1/23

BAGIAN ILMU KESEHATAN MASYARAKAT

FAKULTAS KEDOKTERAN

UNIVERSITAS PATTIMURA

REFERAT

APRIL 2016

IMUNISASI DAN SURVEILENS TERPADU PENYAKIT

Disusun Ole!

DIO OCEV PRATAMA (2009-83-023)

DIBA"AKAN DALAM RANGKA TUGAS KEPANITERAAN KLINIK

PADA BAGIAN ILMU KESEHATAN MASYARAKAT

DINAS KESEHATAN

FAKULTAS KEDOKTERAN

UNIVERSITAS PATTIMURA

AMBON

2016


2/23

IMUNISASI

A. Penda!"!an

Kese#$#n se%#i s#l# s#$u unsu' (ese)#$e'##n u*u* +e'lu ,i-u)u,(#n sesu#i

,enn .i$#/.i$# B#n&s# In,nesi# se%#i*#n# ,i*#(su, ,#l#* UUD 13 *el#lui

+e*%#n&un#n n#sin#l 4#n& %e'(esin#*%unn %e',#s#'(#n P#n.#sil# ,#n UUD 135

Ke%e'#sil#n +e*%#n&un#n (ese#$#n s#n$ ,i+en'ui le $e'se,i#n4# su*%e' ,#4#

*#nusi# 4#n& se#$ $e'#*+il ,#n #li se'$# ,isusun ,#l#* s#$u +'&'#* (ese#$#n

,enn +e'en.#n##n $e'+#,u4#n&,i,u(un&le,#$#,#nin7'*#sie+i,e*il&i4#n&valid 5

Pe*%#n&un#n %i,#n& (ese#$#n ,i In,nesi# s##$ ini *e*+un4#i %e%#n n,#

8double burden9 4#i$u %e%#n *#s#l# +en4#(i$ *enul#' ,#n +en4#(i$ ,e&ene'#$i75

Pe*%e'#n$#s#n +en4#(i$ *enul#' s#n$ suli$ (#'en# +en4e%#'#nn4# $i,#( *en&en#l

%#$#s -il#4# #,*inis$'#si5 I*unis#si *e'u+#(#n s#l# s#$u $in,#(#n +en.e#n

+en4e%#'#n +en4#(i$ (e -il#4# l#in 4#n& $e'%u($i s#n$ cost effective.

Denn i*unis#si +en4#(i$ .#.#' $el# %e'#sil ,i%#s*i ,#n In,nesi# ,in4#$#(#n

%e%#s ,#'i +en4#(i$ .#.#' +#,#$#un 1:5 Menu'u$ Un,#n&/Un,#n& N*' ;6 T#un

200 $en$#n& Kese#$#n i*unis#si *e'u+#(#n s#l# s#$u u+#4# un$u( *en.e

$e')#,in4# +en4#(i$ *enul#' 4#n& *e'u+#(#n s#l# s#$u (e&i#$#n +'i'i$#s Ke*en$e'i#n

Kese#$#n se%#i s#l# s#$u %en$u( n4#$# (*i$*en +e*e'in$# un$u( *en.#+#i

Millennium Development Goals 8 MDGs) (ususn4# un$u( *enu'un(#n #n&(# (e*#$i#n

+#,# #n#(5

Ke&i#$#n i*unis#si ,iselen&'#(#n ,i In,nesi# se)#( $#un 1365 Mul#i $#un

1:: (e&i#$#n i*unis#si ,i+e'lu#s *en)#,i P'&'#* Pen&e*%#nn I*unis#si 8PPI9

,#l#* '#n&(# +en.e#n +enul#'#n $e'#,#+ %e%e'#+# Pen4#(i$ 4#n&D#+#$ Di.e

Denn I*unis#si 8PD;I9 4#i$u Tu%e'(ulsis Di7$e'i Pe'$usis


3/23

I*unis#si #,#l# su#$u .#'# un$u( *enin&(#$(#n (e(e%#l#n sese'#n& se.#'# #($i7

$e'#,#+ su#$u #n$i&en sein& %il# (e$i(# $e'+#)#n +#,# #n$i&en 4#n& se'u+# $i,#(

$e')#,i +en4#(i$5Sesu#i ,enn +'&'#* +e*e'in$# 8De+#'$e*en Kese#$#n9 $en$#n&

P'&'#* Pen&e*%#nn I*unis#si 8PPI9 *#(# #n#( ,i#'us(#n *en,#+#$ +e'lin,unn

$e'#,#+ : )enis +en4#(i$ u$#*# 4#i$u TB< 8,enn e*%e'i#n =#(sin Be'*#n 8,enn +e*%e'i#n MMR9 $i7us '#,#n& sel#+u$ $#( le (u*#n Haemopilus

influen!ae $i+e B 8Hi%9 He+#$i$is A .#.#' #i' ,#n '#%ies5

C. T!'!an I!n%&a&%

Tu)u#n u$#*# i*unis#si #$#u =#(sin#si i#l# +'se,u' *enin&(#$(#n ,e'#)#$ i*uni$#s

*e*%e'i(#n i*uni$#s ,enn *en&in,u(si 'es+ns *e*'i $e'#,#+ +#$&en $e'$en$u

#$#u $(sin ,enn *en&&un#(#n +'e+#'#$ #n$i&en nn/=i'ulen #$#u nn/$(si(5Sel#in i$u

$u)u#n +e*%e'i#n i*unis#si 4#i$u un$u( *enu'un(#n #n&(# (e*#$i#n %#4i ,#n %#li$#

se'$#$e'in,#' ,#'i se'#nn +en4#(i$ #$#u *e*ini*#l(#n &e)#l# s##$ *en,e'i$# s#(i$

$e'se%u$5

D. en%& I!n%&a&%

15 I*unis#si "#)i%

A5 Ru$in#5 I*unis#si,#s#'

T#%el15>#,-#l+e*%e'i#ni*unis#si,#s#'

*e+a,%,%& #

Me'u+#(#n i*unis#si 4#n& ,i&un#(#n un$u( *en.e $e')#,in4# +en4#(i$

e+#$i$is 4#n& (#n,unnn4# #,#l# H%sA& ,#l#* %en$u( .#i' HBsA&

8epatitis " surface antigen9 #,#l# +'$ein 4#n& ,ile+#s(#n le =i'us e+#$i$is

B 4#n& se,#n& *en&in7e(si $u%u5 K#'en# i$u +'$ein ini ,#+#$ ,i&un#(#n

se%#i +en#n,# #$#u *#'(e' $e')#,in4# in7e(si e+#$i$is B5 V#(sin#si


4/23

,i*#(su,(#n un$u( *en,#+#$ (e(e%#l#n #($i7 $e'#,#+ +en4#(i$ He+#$i$is B5

=#(sin $e'%u#$ ,#'i %#&i#n =i'us %e+#$i$is B 4#n& ,in#*#(#n H%sA& 4#n& ,#+#$

*eni*%ul(#n (e(e%#l#n $e$#+i $i,#( *eni*%ul(#n +en4#(i$5Kusus %#&i %#4i

4#n& l#i' ,#'i se'#n& i%u +en&i,#+ =i'us He+#$i$is B #'us ,il#(u(#n

i*unis#si +#si7 *e*#(#i i**un&l%ulin (usus #n$i He+#$i$is B ,#l#* -#($u

2 )#* se$el# (el#i'#n5 Be'i(u$n4# %#4i $e'se%u$ #'us +ul# *en,#+#$

i*unis#si #($i7 2 )#* se$el# l#i' ,enn +en4un$i(#n =#(sin He+#$i$is B

4#n& s#*# se+e'$i %i#s# 4#i$u in$'#*us(ul#'5

aa/. Se,i##n V#(sin He+#$i$is B

V#(sin e+#$i$is #(#n 'us#( (#'en# +e*%e(u#n )u (#'en# +e*#n#s#n5

V#(sin e+#$i$is +#lin& %#i( ,i si*+#n +#,# $e*+e'#$u' 2/?enis =#(sin! #nactivated viral vaccine 8IVV @ HBsA& 4#n& $el#

,iin#($i=#si9

• V#(sin 'e(*%in#n! HB V# 8MSD9 En&e'i 8s*i$ Kline Be.#*9

Bi*u&en 8(##$su(#9

• Pl#s*# ,e'i=e,! He+# B! =#(sin e+#$i$is B 8%i7#'*#9 He+#..ine B

8


5/23

,i'e(*en,#si(#n +#,# u*u' 1/2 %ul#n ,#n (e$i 6/: %ul#n #$#u

%e's#*# ,enn =#(sin .#*+#( +#,# u*u' %ul#n5

• B#4i 4#n& l#i' ,#'i i%u 4#n& $i,#( ,i(e$#ui s$#$us HBsA&n4#

*en,#+#$ 1 ,sis #n#( +l#s*# 'e(*%in#n #$#u 1 ,sis #n#( =#(sin

plasma derived ,#l#* -#($u 12 )#* se$el# l#i'5 Dsis (e,u#

,i'e(*en,#si(#n +#,# u*u' 1/2 %ul#n ,#n (e$i 6/: %ul#n #$#u

%e's#*# ,enn =#(sin .#*+#( +#,# u*u' %ul#n5 Di%e'i(#n

booster 3 $#un (e*u,i#n ,i#n)u'(#n +e*e'i(s##n (#,#' #n$i HBsA&

se%elu*n4#5

/ L(#si Pen4un$i(#n ! Di #n$e'l#$e'#l +##5 Pen4un$i(#n ,i %(n& $#(

,i#n)u'(#n (#'en# un$u( *en&in,#'i (e'us#(#n ne'=us is.i#,i.us5

/ Kn$'# in,i(#si! ,e7isiensi i*un 8*u$l#(9 C s#(i$ %e'#$5

/ T#n,# (e%e'#sil#n! T#( #,# $#n,# (linis 4#n& ,#+#$ ,i)#,i(#n +#$(#n5

N#*un ,#+#$ ,il#(u(#n +en&u(u'#n (e%e'#sil#n *el#lui +e*e'i(s##n

,#'# ,enn *en&e.e( (#,#' e+#$i$is B/n4# se$el# #n#( %e'usi# se$#un5

Bil# (#,#'n4# ,i #$#s 1000 %e'#'$i ,#4# $##nn4# ? $#un ,i#$#s 300 ,#4#

$##n 3 $#un ,i#$#s 200 ,#4# $##n ; $#un5 Te$#+i (#l#u #n&(#n4# .u*#

100 *#(# ,#l#* se$#un #(#n il#n&5 Se*en$#'# %il# #n&(#n4# 0 %e'#'$i si

%#4i #'us ,isun$i( ul#n& ; (#li l#&i5

/ Tin&(#$ (e(e%#l#n!


6/23

'isi( $u%e'.ulsis %e'#$ se+e'$i *enin&i$is$u%e'(uls# ,#n $u%e'.ulsis *ilie'5

E7e( +'$e(si $i*%ul ?/12 *in&&u se$el# +en4un$i(#n5 E7e( +'$e(si %e'=#'i#si

#n$#'# 0/?0 5 H#l ini *un&(in (#'en# =#(sin 4#n& ,i+#(#i lin&(unn ,enn

M4.%#.$e'iu* #$i+i( #$#u 7#($' +e)#*u 8u*u' (e#,##n &ii ,ll95

I*unis#si ini .u(u+ ,i%e'i(#n s#$u (#li s#)#5 Bil# +e*%e'i#n i*unis#si ini

%e'#silJ *#(# se$el# %e%e'#+# *in&&u ,i $e*+#$ sun$i(#n #(#n $i*%ul le+u#n

(e.il #$#u ul(us5 Ul(us 4#n& $e'%en$u( $i,#( *enn&&u s$'u($u' $$ se$e*+#$

8,i%#n,in&(#n +e*%e'i#n ,i ,#e'# &lu$e#l l#$e'#l #$#u +## #n$e'i'95

aa/. V#(sin Benis V#(sin!


7/23

,il#(u(#n u)i $u%e'li(#n $e'le%i ,#ulu5 V#(sin B#,i

*es(i %isul $#( *un.ul #n$i%,i $e$#+ $e'%en$u( #n4# s#)# ,#l#* (#,#'

'en,#5 I*unis#si +un $#( +e'lu ,iul#n& (#'en# ,i ,#e'# en,e*is TB

in7e(si #l#*i# #(#n sel#lu #,#5 Denn (#$# l#in #n#( #(#n *en,#+#$

=#(sin#si #l#*i#5>i(# $i,#( #,# le+u#n 4#n& $i*%ul %is# s#)# ,i(#'en#(#n

.#'# +en4un$i(#n 4#n& s#l# *en&in$ .#'# *en4un$i((#nn4# +e'lu

(e#li#n (usus (#'en# =#(sin #'us *#su( (e ,#l#* (uli$5 A+#l#&i %il#


8/23

,il#(u(#n ,i +## +'ses *en4un$i((#nn4# le%i suli$ (#'en# l#+is#n le*#(

,i %#-# (uli$ +## u*u*n4# le%i $e%#l5

DPT(D%$,e/%a1 Pe/,!&%&1 dan Te,an!&)

I*unis#si DPT #,#l# su#$u =#(sin 4#n& *elin,un&i $e'#,#+ ,i7$e'i +e'$usis,#n $e$#nus5 Di7$e'i ,ise%#%(#n %#($e'i 4#n& *en4e'#n& 7#'in& ,#n ,#+#$

*en4e%#%(#n (*+li(#si 4#n& se'ius #$#u 7#$#l5 Bi#s#n4# =#(sin ,i7$e'i# ,il#

,#n ,i(e*#s %e's#*##n ,enn =#(sin Te$#nus 8DT9 #$#u ,enn =#(sin

Te$#nus ,#n Pe'$usis 8DPT95 Pen4#(i$ ini *u,# *enul#' *el#lui %#$u( #$#u

%e'sin5 Pe'$usis 8%#$u( 'e)#n9 #,#l# in7e(si %#($e'i +#,# s#lu'#n n#+#s 4#n&

,i$#n,#i ,enn %#$u( e%#$ 4#n& *ene$#+ se'$# %un4i +e'n#7#s#n 4#n&

*elen&(in&5

aa/. Se,i##n V#(sin TT ,#n DT

Pe'$usis )u ,#+#$ *eni*%ul(#n (*+li(#si se'ius se+e'$i +eneu*ni# (e)#n&,#n (e'us#(#n $#(5 Te$#nus #,#l# in7e(si %#($e'i 4#n& %is# *en4e%#%(#n

(e(#(u#n +#,# '##n& se'$# (e)#n&5 I*unis#si ini *e'u+#(#n =#(sin .#i'

(*+sisi $i#+ *l *enn,un& $(si, ,i7$e'i 4#n& ,i*u'ni(#n 0 L7 $(si,

$e$#nus 4#n& ,i*u'ni(#n 13 L7 B +e'$ussis 4#n& ,iin#($i=#si 2 OU

Alu*iniu* 7s7#$ ; *& Ti*e's#l 01 *&5

- >enis =#(sin! Di7$e'i 8$(si,9 Pe'$usis 8 #nactivated "acterial

accine/IBV B',e$ell# +e'$usis $i+e I9 Te$#nus 8$(si,9

- Dsis! 03 *LC,sis- #,-#l i*unis#si !

I*unis#si ,#s#'! / Ti ,sis ,enn in$e'=#l /6 *in&&u5

/ Dsis I ,i%e'i(#n +#,# u*u' 2 %ul#n5

• Bs$e'! Dsis IV ,i%e'i(#n 1 $#un se$el# ,sis III5 Dsis V se'$# VI

%e'u+# DT ,i%e'i(#n +#,# u*u' 6 ,#n 12 $#un5

/ Kn$'# in,i(#si! De7isiensi i*un 8*u$l#(9 ,i7$e'i 8$i,#( #,#9 +e'$usis

8'i-#4#$ (el#in#n neu'l&is s(e*# i*unis#si DPT +#,# %#4i ,enn

'i-#4#$ (e)#n&9 Te$#nus 8$i,#( #,#9


9/23

/ E7e( s#*+in& ! Re#(si l(#l ,e*#* 'e#(si #(ine$i( (e)#n& &e)#l#

ense7#l+#$i #(i%#$ =#(sin +e'$usis5 Un$u( #n#( 4#n& *e*ili(i 'i-#4#$

(e)#n& ,e*#* i*unis#si DPT $e$#+ #*#n5 Ke)#n& ,e*#* $#(

*e*%##4#(#n (#'en# #n#( *enl#*i (e)#n& #n4# (e$i(# ,e*#* ,#n

$#( #(#n *enl#*i (e)#n& l#&i se$el# ,e*#*n4# il#n&5 >i(# '#n& $u#

(#-#$i' ,#+#$ ,i%e'i(#n =#(sin DTP #sesel#' 4#n& $#( *eni*%ul(#n

,e*#*5 K#l#u+un $e')#,i ,e*#* u*u*n4# s#n$ 'inn51/;

P"%

I*unis#si +li *e*%e'i(#n (e(e%#l#n $e'#,#+ +en4#(i$ +li5 Pen4#(i$ ini

,ise%#%(#n =i'us *en4e%#' *el#lui $in)#C($'#n '#n& 4#n& $e'in7e(si5 An#(

4#n& $e'(en# +li ,#+#$ *en)#,i lu*+u l#4u5 V#(sin +li #,# ,u# )enis

4#(ni !

* Inactived Poliomyelitis Vaccine (IPV)

Di In,nesi# *es(i+un su,# $e'se,i# $e$#+i V#(sin Pli In#.$i=#$e, #$#u

In#.$i=e, Pli*4eli$is V#..ine 8IPV9 %elu* %#n4#( ,i&un#(#n5 IPV

,i#sil(#n ,enn .#'# *e*%i#((#n =i'us ,#l#* *e,i# +e*%i#((#n

(e*u,i#n ,i%u#$ $i,#( #($i7 8in#.$i=#$e,9 ,enn +e*#n#s#n #$#u %##n

(i*i#5 K#'en# IPV $i,#( i,u+ ,#n $i,#( ,#+#$ 'e+li(#si *#(# =#(sin ini

$i,#( ,#+#$ *en4e%#%(#n +en4#(i$ +li -#l#u+un ,i%e'i(#n +#,# #n#( ,enn ,#4# $##n $u%u 4#n& le*#5 V#(sin 4#n& ,i%u#$ le A=en$is

P#s$eu' ini %e'isi $i+e 12; ,i%i#((#n +#,# sel/sel VERO &in)#l (e'# ,#n

,i%u#$ $i,#( #($i7 ,enn 7'*#,ei,5Sel#in i$u ,#l#* )u*l# se,i(i$

$e',#+#$ ne*isin s$'e+$*isin ,#n +li*i(sin B5 IPV #'us ,isi*+#n +#,#

suu 2 ? < ,#n $i,#( %le ,i%e(u(#n5 Pe*%e'i#n =#(sin $e'se%u$ ,enn

.#'# sun$i(#n su%(u$#n ,enn ,sis 03 *l ,i%e'i(#n ,#l#* (#li %e'$u'u$/

$u'u$ ,#l#* )#'#( 2 %ul#n5Un$u( '#n& 4#n& *e*+un4#i (n$'#in,i(#si #$#u

$i,#( ,i+e'%le(#n *en,#+#$(#n OPV *#(# ,#+#$ *en&&un#(#n IPV5

De*i(i#n +ul# %il# #,# se'#n& (n$#( 4#n& *e*+un4#i ,#4# $##n $u%u

4#n& le*# *#(# %#4i ,i#n)u'(#n un$u( *en&&un#(#n IPV5

* Oral Polio Vaccine (OPV)

>enis =#(sin Vi'us Pli O'#l #$#u O'#l Pli V#..ine 8OPV9 ini +#lin&

se'in& ,i+#(#i ,i In,nesi#5 V#(sin OPV +e*%e'i#nn4# ,enn .#'#

*ene$es(#n .#i'#n *el#lui *ulu$5 V#(sin ini $e'%u#$ ,#'i =i'us li#' 8-il,9

i,u+ 4#n& ,ile*#(#n5 OPV ,i In,nesi# ,i%u#$ le PT Bi7#'*#B#n,un&5 K*+sisi =#(sin $e'se%u$ $e',i'i ,#'i =i'us Pli $i+e 1 2 ,#n ;


10/23

4#n& *#si i,u+ $e$#+i su,# ,ile*#(#n 8#$$enu#$e,95 V#(sin ini ,i%u#$

,#l#* %i#(#n )#'inn &in)#l (e'# ,#n ,is$#%il(#n ,#l#* su.'s#5 Ti#+ ,sis

se%#n4#( 2 $e$es *enn,un& =i'us $i+e 1 $i+e 2 ,#n $i+e ; se'$#

#n$i%i$i(# e'i$'*isin $i,#( le%i ,#'i 2 *.& ,#n (#n#*isin $i,#( le%i ,#'i

10 *.&5

Vi'us ,#l#* =#(sin ini se$el# ,i%e'i(#n 2 $e$es #(#n *ene*+#$(#n ,i'i ,i

usus ,#n *e*#.u +e*%en$u(#n #n$i%,i %#i( ,#l#* ,#'# *#u+un ,#l#*

,in,in& lu#' l#+is#n usus 4#n& *en(i%#$(#n +e'$##n l(#l $e'#,#+ =i'us

+li li#' 4#n& #(#n *#su(5 Pe*%e'i#n Ai' susu i%u $i,#( %e'+en'u +#,#

'es+n #n$i%,i $e'#,#+ OPV ,#n i*unis#si $i,#( %ile ,i$un,# (#'en#

#l ini5 Se$el# ,i%e'i(#n ,sis +e'$#*# ,#+#$ $e'lin,un&i se.#'# .e+#$

se,#n&(#n +#,# ,sis %e'i(u$n4# #(#n *e*%e'i(#n +e'lin,unn )#n&(#

+#n)#n&5 V#(sin ini ,i%e'i(#n +#,# %#4i %#'u l#i' 261? %ul#n ,#n 3

$#un5

aa/. Se,i##n V#(sin Pli

>enis =#(sin! =#(sin +li '#l s#%in 8LAV9

Dsis! 2 $e$esC,sis 803 *l9

i(# B


11/23

• Kn$'#in,i(#si ! De7isiensi i*un 8*u$l#(9 ,i#'e 8se*en$#'#9 $#(

,#+#$ ,i%e'i(#n +#,# #n#( 4#n& *en,e'i$# +en4#(i$ #(u$ #$#u

,e*#* $in&&i 8,i #$#s ;?0


12/23

s#*+#i #'i (e ,el#+#n se$el# +en4un$i(#n5 Mun&(in +ul# $e',#+#$

+e*%en&(#(#n +#,# $e*+#$ sun$i(#n5

/ +enis va%sin! S.-#' 8LAV9

/ Dosis! 03 *LC,sis

/ ,ara pemberian! S< #$#u IM

/ +awual imunisasi!

• I*unis#si ,#s#' ! ,i%e'i(#n +#,# u*u' %ul#n

• Bs$e'! $i,#( ,i+e'lu(#n )i(# su,# *en,#+#$(#n MMR

/ &ontra indi%asi!

• De7isiensi i*un 8*u$l#(9

• Ale'&i $e'#,#+ $elu' 8%en#'/%en#' $e'%u($i9

• Men,#+#$ in)e(si **#&l%ulin ,#l#* 6 *in&&u $e'#(i'

/ Efe% samping ! ,e*#* ,enn #$#u $#n+# 'u#* 6/12 #'i se$el#

,ii*unis#si +#,# 13/20 #n#(5

%5 I*unis#si L#n)u$#n

I*unis#si l#n)u$#n *e'u+#(#n (e&i#$#n 4#n& %e'$u)u#n un$u( *elen&(#+i

i*unis#si ,#s#' +#,# %#4i 4#n& ,i%e'i(#n (e+#,# #n#( B#$i$# #n#( usi# se(l#

,#n -#ni$# usi# su%u' 8"US9 $e'*#su( i%u #*il5 I*unis#si l#n)u$#n +#,# "US

s#l# s#$un4# ,il#(s#n#(#n +#,# -#($u *el#(u(#n +el#4#n#n #n$en#$#l5

T#%el25 >#,-#li*unis#sil#n)u$#n+#,##n#(%#-#$i$#un

T#%el ;5 >#,-#li*unis#sil#n)u$#n+#,##n#(usi#se(l#,#s#'

T#%el5 I*unis#siL#n)u$#nP#,#"#ni$#Usi#Su%u'8"US9


13/23

B5 I*unis#si T#*%##n

Y#n& $e'*#su( ,#l#* (e&i#$#n i*unis#si $#*%##n #,#l#!

#5 "ac% log figting

Me'u+#(#n u+#4# #($i7 un$u( *elen&(#+i i*unis#si ,#s#' +#,# #n#( 4#n&

%e'u*u' ,i%#-# ; 8$i $#un5 Ke&i#$#n ini ,i+'i'i$#s(#n un$u(

,il#(s#n#(#n ,i,es# 4#n& sel#*# 2 8,u#9 $#un %e'$u'u$/$u'u$ $i,#(

*en.#+#i U


14/23

se%elu*n4#5 Pe*%e'i#n i*unis#si .#*+#( +#,# -#($u catc up campaign

.#*+#( ,is#*+in& un$u( *e*u$us '#n$#i +enul#'#n )u %e'&un# se%#i

booster #$#u i*unis#si ul#nn 8,sis (e,u#95

75 I*unis#si ,#l#* Pen#nn#n KLB 8-utbrea% $esponse

#mmuni!ation -$# 9

Pe,*#n +el#(s#n##n i*unis#si ,#l#* +en#nn#n KLB ,isesu#i(#n

,enn si$u#si e+i,e*il&is +en4#(i$ *#sin&/*#sin&5


15/23

+en4#(i$ ,#'i *#sin&/*#sin& +en4#(i$5 Y#n& $e'*#su( ,#l#* i*unis#si +ili#n

ini#,#l#!

A5 V#(sin Measles2 Mumps2 $ubella!

B5 Haemopilllusinfluen!ae tipeb(Hib)

#+#nese Ense+#li$is

>5 Hu*#n P#+il*# Vi'us

E. Ca!+an I!n%&a&% D% Ma"!!

Ca!+an I!n%&a&% *#0 +e/ Ka!+a,en K,a P/4%n&% Ma"!! ,a!n 2056

0

10

20

30

40

50

6070

80

90

100 91.1

75.4

64.8

56.6 54.348.8

43.5

31.926.2 24.5

16.8

56.6

2014

D#'i ,#$# ,i#$#s ,#+#$ ,isi*+ul(#n .#(u+#n HB0 *#si %e'#,# ,i%#-# $#'&e$ ,es#

U


16/23

0

20

40

60

80

100

120 10798.5

92.1 89.284.1

79.1 77.8 76 73.3 69.8 69.7

84.2

2014


17/23

0

20

40

60

80

100

120100.8 97.6 94.4

85.1 85.178.8 77 76.7 76 73.7

59.3

84.7

2014

D#$# i*unis#si +li +#,# 11 (#%u+#$en *#si %#n4#( 4#n& %elu* *en.#+#i $#'&e$

05

Ca!+an I!n%&a&% Ca+a +e/ Ka!+a,en K,a P/4%n&% Ma"!! ,a!n 2056

0

20

40

60

80

100

120101.5

95.4 92.6 89.5 88.8 88.6 87.3 84.678

70 67.7

87.4

2014

B#n4#( (#%u+#$en 4#n& %elu* 4#n& i*unis#si .#*+#(n4# *#si %e'#,# ,i .#(u+#n

'en,#5

Ca!+an I!n%&a&% Da&a/ Lena+ +e/ Ka!+a,en K,a P/4%n&% Ma"!! ,a!n

2056


18/23

0

10

20

30

40

5060

70

80

90

100 90.1 88.2 87.5 86.8 85.9 82.8

70.4 67.6

59.1

31.8 29.5

75

2014

Ti,#( #,# (#%u+#$enC($# 4#n& *en.#+#i $#'&e$ i*unis#si ,#s#' len&(#+

Ca!+an De&a UCI +e/ Ka!+a,en K,a P/4%n&% Ma"!! ,a!n 2056

0

10

20

30

40

50

60

70

80

90

90 88.5 87.5

80.2 8074.4 74.1 72.3

58.7

42.5

31.6

70

2014

D#'i 11 (#%u+#$en ,i M#lu(u #n4# #,# 3 (#%u+#$en 8 K$# A*%n M#lu(u Ten&'#

M#lu(u Ten MTB ,#n K$# Tu#l9 4#n& *en.#+#i $#'&e$ Des# U


19/23

SURVEILENS PELAYANAN TERPADU PENYAKIT

Su'=eil#ns $e'+#,u +en4#(i$ 8STP9 Di#$u' ,#l#* l#n,#s#n (u* KEPMENKES

RI N5 1:CMENKESCSKCQC200; $en$#n& Pe,*#n Pen4elen&'##n Sis$e* Su'=eil#ns

E+i,e*il&i Pen4#(i$ Menul#' ,#n Pen4#(i$ Ti,#( Menul#' Te'+#,u5 Denn $u)u#n u*u*

Diperolehnya informasi epidemiologi penyakit tertentu dan terdistriusinya

informasi terseut kepada program terkait! pusat"pusat ka#ian dan pusat

penelitian serta unit sur$eilans lain. Tu)u#n (usus %e'u+# $e'(u*+ul $e'l#(s#n#n4#

+en&l##n ,#n +en4#)i#n ,#$# ! (es#(i$#n l#%'#$'iu* ,#n KLB +en4#(i$ ,#n (e'#.un#n ,i

uni$ +en&u*+ul ,#$# ,#n $e',is$'i%usin4# ,#$# ,#n #sil +en&l##n ,#$# ! (es#(i$#n

l#%'#$'iu* ,#n KLB +en4#(i$ C(e'#.un#n +#,# uni$ $e'(#i$

Pen4elen&'# STP #,#l# !

15 STP %e'su*%e' ,#$# Pus(es*#s

25 STP %e'su*%e' ,#$# RS

;5 STP %e'su*%e' ,#$# L#%'#$'iu*

5 STP %e'su*%e' ,#$# Pus(es*#s Sen$inel

35 STP %e'su*%e' ,#$# RS Sen$inel

65 STP %e'su*%e' ,#$# KLB +en4#(i$ (e'#.un#n

P#,# STP %e'su*%e' ,#$# Pus(es*#s $en$#n& 23 +en4#(i$ *enul#' se,#n&(#n STP

%e'su*%e' ,#$# RS *en&en#i 23 +en4#(i$ +us(es*#s +en4#(i$ *enul#' l#inn4# STP

%e'su*%e' ,#$# L#% *en&en#i ? +en4#(i$ $es 'esis$/ sensi$i=i$#s5


20/23

Pen4#(i$ 4#n& $e'*#su( ,#l#* +en4#(i$ *enul#' #,#l#! Kle'# *#l#'i# (linis

,i#'e5 *#l#'i# =i=# ,i#'e %e',#'# *#l#'i# 7#lsi7#'u*5 $i7us +e'u$ (linis *#l#'i# *i $%

+#'u %$# 89 %,' ,en&ue $% +#'u (linis ,e*#* ,en&ue (us$# +% +neu*ni# (us$# *%

si7ilis .#*+#( &n''e# ,i7$e'i 7'#*%usi# %#$u( 'e)#n 7il#'i#sis $e$#nus in7luen# ,#n

e+#$i$is (linis5 Se,#n&(#n +en4#(i$ +#,# %#&i#n l#%'#$'iu* #,#l# Kle'# $i7us +e'u$

-i,#l C(ul$u'89 ,i7$e'i e+#$i$is %s#&89 *#l#'i# =i=# *#l#'i# 7#lsi7#'u* *#l#'i# *i

en$e'=i'us 'esis$ensi ,#n sensi$i=i$#s $es$5

Se,#n&(#n STP %e'su*%e' ,#$# Pus(es*#s sen$inel $e',i'i ,#'i 23 +en4#(i$ *enul#' 2

+en4#(i$ $i,#( *eul#' un$u( STP %e'su*%e' ,#$# RS sen$inel $e',i'i ,#'i 2 +en4#(i$

*enul#' ,#n 20 +en4#(i$ $i,#( *enul#'5

K'i$e'i# Sen$inel !

PUSKESMAS

1 +us(es*#s ,i$e$#+(#n le Din(es (#%C($#

Mu,# ,i)#n&(#u ,#'i i%u($# (#%C($#

>u*l# $en# .u(u+

M#n#)e*en RR 4#n& %#i(

RUMAH SAKIT

Se*u# RS $i+e A B ,#n 1 RS $i+e l#inn4# ,i$e$#+(#n le Din(es (#%C($#

Mu,# ,i)#n&(#u ,#'i i%u($# (#%C($#

>u*l# $en# .u(u+

M#n#)e*en RR 4#n& %#i(

V#'i#%el ,#$# STP 4#n& #'us ,il#*+i'(#n #,#l#!

>enis +en4#(i$ (,e sesu#i I


21/23

>enis (el#*in 8$$#l l#(i/l#(i +e'e*+u#n9

>u*l# (un)unn sesu#i )enis +en4#(i$

>u*l# (un)unn T$#l

>u*# (e*#$i#n 8#n4# un$u( RS R#-#$ In#+9

Kelen&(#+#n ,#n Ke$e+#$#n L#+'#n

H#sil +e*e'i(s##n l#% 8+si$i7Cne$i79 % STP L#%

Ke&i#$#n ,#'i STP #n$#'## l#in!

Pul$# Pen&l##n D#$#

L#+'#n STP $i#+ %ul#n

Dil# ,enn s7$ -#'e

An#lisis

Des('i+$i7 " T O

U*+#n B#li(

Pe'%#i(#n

P'esensi

Dise*in#si

Bu(u D#$# T#un#n

In,i(#$' (ine')# ,#'i STP ,#+#$ ,ili#$ ,#'i !

15 Se$i#+ KLB 4#n& $e')#,i ,#+#$ ,i$#n&&ul#n&i 2 )#* se%es#' 100 8$#un 2019

25 Uni$ +el#4#n#n ! Kelen&(#+#n l#+'#n se%es#' 0 (e$e+#$#n se%es#' ?05

;5 Din#s Kese#$#n K#%u+#$enCK$# *en.#+#i in,i(#$' e+i,e*il&i STP se%es#' ?0

5 Din#s Kese#$#n K#%CK$# ! Kelen&(#+#n l#+'#n se%es#' 100 (e$e+#$#n se%es#'

05


22/23

35 Din#s Kese#$#n P'=insi ! Kelen&(#+#n l#+'#n se%es#' 100 (e$e+#$#n se%es#'

05

65 Dis$'i%usi ,#$# ,#n in7'*#si %ul#n#n K#%u+#$enCK$# P'+insi ,#n N#sin#l

se%es#' 1005

:5 U*+#n %#li( l#+'#n %ul#n#n K#%u+#$enCK$# P'+insi ,#n N#sin#l se%es#' 1005

?5 Pene'%i$#n %ule$in e+i,e*il&i ,i K#%u+#$enCK$# #,#l# (#li se$#un5

5 Pene'%i$#n %ule$in e+i,e*il&i ,i P'+insi ,#n N#sin#l #,#l# se%es#' 12 (#li

se$#un5

105 Pene'%i$#n +'7il $#un#n #$#u %u(u ,#$# su'=eil#ns e+i,e*il&i K#%u+#$enCK$#

P'+insi ,#n N#sin#l #,#l# s#$u (#li se$#un5

T#n$#nn 4#n& se'in& ,i#,#+i #,#l#

• Kine')# STP *enl#*i +enu'un#n % Kelen&(#+#n ,#n (e$e+#$#n $#'&e$5

• I*+le*en$#si STP l#%'#$'iu* %u$u +e'#$i#n

• Fun&si STP se%#i %##n +e'en.#n##n ,#n in$e'=ensi %elu* +$i*#l

• Fun&si STP %e'%e,# ,enn SKD/KLB

• Pe*#n7##$#n #sil #n#lisis STP se%#i %##n ,ise*in#si in7'*#si5

• Pe*enu#n SDM 4#n& %e'$#n&&un& )#-#% un$u( STP 8RS Pus( L#% KLB9

• Se'$# +e'#n ,#n (es#,#'#n *#s4#'#(#$5


23/23

DAFTAR PUSTAKA

15 Ke+u$us#n Men$e'i Kese#$#n Re+u%li(

In,nesi# n*'! ?2CMen(esCSKC20105 Ten$#n&

Ge'#(#n A(sel#'#si I*unis#si N#sin#l Uni=e's#l

#(#'$#201;

;5 S#$s I*unis#si IDAI5 >#,-#l I*unis#si

Re(*n,#si IDAI5 >#(#'$#5 2000518295;/:

5 Ke*en$'i#n Kese#$#n Re+u%li( In,nesi#5

Bule$in >en,el# D#$# ,#n In7'*#si Kese#$#n

Eli*in#si Te$#nus M#$e'n#l ,#n Nen#$#l5 >#(#'$#

2012

Imunisasi Word Print

Documents

Transcript of Imunisasi Word Print